Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
Should Merck Buy Out Moderna on Keytruda–Cancer Vaccine Partnership?
BioSpace
Wed, 07/24/24 - 11:02 pm
Merck
Moderna Therapeutics
cancer vaccines
Keytruda
Merck, Rapt, Aslan and more cut staff
Pharma Live
Wed, 07/24/24 - 11:58 am
layoffs
Merck
RAPT Therapeutics
Aslan Pharma
Caribou Biosciences
Novartis
Spark Therapeutics
Merck claims late-stage study success for RSV antibody
BioPharma Dive
Tue, 07/23/24 - 11:36 am
Merck
RSV
infants
clesrovimab
antibdodies
Merck launches GMP-compliant cell culture media line in China
Pharmaceutical Business Review
Wed, 07/17/24 - 12:13 pm
Merck
China
drug manufacturing
cell culture media
cell culture
Novo Nordisk's Ozempic cuts dementia risk compared with Merck's Januvia: Oxford study
Fierce Pharma
Fri, 07/12/24 - 11:28 am
Novo Nordisk
Ozempic
dementia
Merck
Januvia
Merck puts 1,000-plus Zostavax lawsuits to bed after plaintiffs file for dismissal
Fierce Pharma
Tue, 07/9/24 - 11:23 am
Merck
Zostavax
vaccines
shingles
legal
Merck opts in on Orion's hormone-dependent cancer candidates
Fierce Biotech
Mon, 07/1/24 - 09:51 pm
Merck
Orion
biobucks
cancer
Merck's Capvaxive gears up to challenge Pfizer's dominant Prevnar with CDC panel backing
Fierce Pharma
Sun, 06/30/24 - 09:59 pm
Merck
Pfizer
vaccines
pneumococcal disease
Prevnar
Capvaxive
This Recent FDA Approval Is Bad News for Pfizer
Motley Fool
Thu, 06/27/24 - 11:31 am
Pfizer
Merck
FDA
vaccines
pneumococcal disease
FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug
Reuters
Thu, 06/27/24 - 11:18 am
Merck
Daiichi Sankyo
cancer
FDA
patritumab deruxtecan
antibody-drug conjugate
Merck's Keytruda snags 40th US indication, leaps ahead of GSK with broad endometrial cancer approval
Fierce Pharma
Tue, 06/18/24 - 11:40 am
Merck
Keytruda
endometrial cancer
GSK
FDA
Merck gets shot in the arm with FDA approval for first pneumococcal vaccine designed for adults
Fierce Pharma
Mon, 06/17/24 - 10:37 pm
Merck
vaccines
FDA
pneumococcal disease
Capvaxive
V116
Merck looks for next-generation opportunities in cardiometabolic drugs
Reuters
Tue, 06/11/24 - 11:23 am
Merck
cardiometabolic diseases
weight loss
ASCO: With Opdivo-Yervoy combo, Bristol Myers calls Roche and AstraZeneca's bets in first-line liver cancer
Fierce Pharma
Tue, 06/4/24 - 11:52 am
ASCO 2024
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
Merck
Eisai
Bayer
Lenvima
Nexavar
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters
Mon, 06/3/24 - 11:58 am
Moderna Therapeutics
Merck
skin cancer
melanoma
vaccines
Keytruda
'We're going to miss the next Keytruda': Lilly, Merck, Gilead and PhRMA CEOs talk IRA consequences
Fierce Pharma
Mon, 06/3/24 - 11:54 am
Merck
Eli Lilly
Gilead Sciences
innovation
Inflation Reduction Act
Keytruda
PhRMA
Smaller Biopharma M&A on Upswing, Deals Expected to Continue Through 2024
BioSpace
Fri, 05/31/24 - 10:59 am
M&A
Merck
EyeBio
JNJ
Numab Therapeutics
Asahi Kasei
Calliditas Therapeutics
Merck’s potential $3B EyeBio acquisition puts drugmaker back in ophthalmology
BioSpace
Wed, 05/29/24 - 11:54 am
Merck
EyeBio
ophthalmology
M&A
How Merck for Mothers reached 30M women through maternal health programs
Medical Marketing and Media
Mon, 05/20/24 - 05:48 pm
Merck
maternal health
Women's Health
pharma marketing
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Big Pharma
Eli Lilly
Mounjaro
Novo Nordisk
Wegovy
JNJ
Tecvayli
Merck
Vaxneuvance
AbbVie
Qulipta
AstraZeneca
Saphnelo
Novartis
Leqvio
Roche
Genentech
Vabysmo
Amgen
Evenity
Pfizer
Vyndaqel
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »